Enabling low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of essential medicines and related pharmaceutical services.
Improving pharmaceutical services, including product availability and patient-centered care, to achieve health outcomes
Increasing the availability and use of pharmaceutical information for decision making and advancing the global learning agenda
Increasing institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products
By Dr. Doris Lutkam, MTaPS Senior Technical Advisor
View More Stories
Approximately 10% of hospital procedures in low- and middle-income countries result in a health care-acquired infection.
Pharmaceutical systems strengthening (PSS) plays a pivotal role in achieving universal health coverage (UHC) by ensuring access to safe, effective, quality, and affordable essential medical products and their appropriate use.
With the support of the USAID MTaPS program, a new mentorship activity has helped health care facilities launch new efforts to ensure the appropriate use of antimicrobials to combat antimicrobial resistance (AMR).
